INTRODUCTION
Influenza A virus (IAV) is an upper respiratory pathogen in humans with the ability to rapidly evolve, resulting in both seasonal epidemics and occasional pandemics (Wright et al., 2013) . As the constant emergence of variant-and drug-resistant strains greatly reduce the efficacy of current vaccines and therapies, there remains a need for host-directed therapeutics against IAVs. Multiple genome-wide screening approaches, including small interfering RNA (siRNA), proteomic, and insertional mutagenesis screens, have been employed to identify host factors involved in IAV infection Kö nig et al., 2010; Benitez et al., 2015; . Although some common hits and pathways were revealed, most notably members of the vacuolar ATPase family, meta-analyses demonstrated little overlap in the identified IAV host factors, likely because of differences in the strains used, time points assayed, and functional readouts chosen (Mehle and Doudna, 2010; Stertz and Shaw, 2011; Watanabe et al., 2010) . Therefore, alternative screening strategies will provide the flexibility needed to uncover host factors and pathways, as well as validate previously identified hits, to serve as potential targets for the development of anti-influenza therapeutics.
Recent advancements in CRISPR/Cas9 technology have allowed for gene disruption on a genome-wide scale in mammalian cells Wang et al., 2014; Wright et al., 2016) . Recently, the GeCKO (genome-wide CRISPR knockout) screening strategy has been utilized to investigate virus-host interactions (Haga et al., 2016; Ma et al., 2015; Marceau et al., 2016; Orchard et al., 2016; Park et al., 2017a; Savidis et al., 2016; Zhang et al., 2016) . Here, we generated a GeCKO library in human lung epithelial (A549) cells negatively selected against genes essential for cell viability and subjected this A549-GeCKO library to five rounds of lethal infection with a human isolate of an avian IAV strain. Deep sequencing analysis of the enriched single guide RNA (sgRNA) population identified numerous genes involved in the sialic acid biosynthesis and glycosylation pathways, as well as in the regulation of cell-intrinsic immunity. Validation studies revealed host factors critical for multiple IAV strains that function at different stages of viral replication, including entry and antiviral responses. Loss of SLC35A1, a CMP-sialic acid transporter, rendered cells resistant to IAV infection because of the absence of cell-surface sialic acids. Furthermore, GeCKO screening identified capicua (CIC), a DNA-binding transcriptional repressor, as a negative regulator of cell-intrinsic immunity. Loss of CIC resulted in upregulation of antiviral responses and restricted replication of viruses from diverse families. Taken together, our studies demonstrate that GeCKO screening is a versatile strategy that can be utilized to identify host factors critical for IAV replication.
RESULTS

Generation of an A549-GeCKO Library
To identify host genes critical for IAV replication, we generated a GeCKO library in A549 cells as previously described and performed a genome-scale loss-of-function genetic screen Wang et al., 2014; Zhang et al., 2016) . First, we derived Steps 5-7: the A549-GeCKO library was infected with a low-pathogenic H5N1 (VN04 Low ) to obtain resistant cells. Steps 8a-9: preliminary consecutive screen: surviving cells were subjected to a total of five rounds of H5N1 infection with minimal expansion of resistant cells. Steps 8b-9: sequential screen: surviving cells were subjected to a total of five rounds of H5N1 infection with substantial expansion of resistant cells between each round.
Step 10: validation and characterization of selected hits. (B) Boxplot of sgRNA distribution in the A549-GeCKO library and after each round (Rd) of the sequential screen. Biological replicates are shown as Rep1 and Rep2; values are represented in log 2 scale; and sgRNAs are median-normalized to account for differences in total Illumina read counts. Each point represents a clonal Cas9-expressing A549 cell line (Cas9-A549s) by transducing wild-type (WT) A549 cells with lentivirus expressing the Cas9 gene ( Figure 1A , step 1). Next, Cas9-A549s were transduced with lentivirus containing a pooled human genome-wide sgRNA library (library A) of 65,383 sgRNAs targeting 19,050 protein-coding genes and 1,864 microRNA (miRNA) precursors and selected in puromycin for 14 days ( Figure 1A , steps 2-4) . To evaluate sgRNA diversity in the A549-GeCKO library, we PCR-amplified the integrated sgRNA cassettes from genomic DNA and subjected them to Illumina sequencing. Analysis of the 9 M reads obtained from 1 3 10 8 cells revealed the presence of 62,659 sgRNAs (R10 reads) in the A549-GeCKO library, representing an average coverage of $1403 per sgRNA ( Figures S1A and S1B ). The loss of $4.2% of sgRNAs post-puromycin selection likely suggests the negative selection of a non-viable cell population. Thus, we successfully generated a pooled GeCKO library in A549 cells with sufficient coverage to perform genetic screens for IAV host factors.
Preliminary Screen for Positive Selection of H5N1-Resistant Cells in the A549-GeCKO Library
To enrich for a cell population resistant to IAV replication, we subjected the A549-GeCKO library to lethal infection with a human isolate of a low pathogenic avian H5N1 virus (A/Vietnam/ 1203/04, VN04 Low ; Figure 1A , steps 5-7). For our preliminary GeCKO screen, we performed five consecutive rounds (Rd) of lethal infection with minimal expansion of cells between rounds (preliminary consecutive screen); the resistant cells were subsequently expanded, and sgRNA distribution was assessed by Illumina sequencing (Prelim Rd5; Figure 1A , steps 8a-9). For the 8 M Illumina reads obtained from Prelim Rd5, we observed robust enrichment of 586 sgRNAs (R10 reads) representing $1% of the sgRNAs present in the A549-GeCKO library (Figures S1A and S1C). Next, candidate genes were identified and ranked using the model-based analysis of genome-wide CRISPR/Cas9 knockout (MAGeCK) program . We observed positive selection of 119 genes in Prelim Rd5 (p < 0.1), with the SLC35A1 gene (sialic acid transporter) ranked highest and demonstrating representation by all 3 independent sgRNAs (Table S1 ). Interestingly, the remaining genes showed enrichment for a single sgRNA, likely because of the stringent selection achieved by performing five consecutive rounds of lethal infection with minimal expansion of cells between rounds. Together, our preliminary screen identified potential host factors whose loss rendered cells highly resistant to H5N1 infection.
Analysis of sgRNA Enrichment during Sequential H5N1 Selection Next, we performed a less stringent GeCKO screen by allowing for substantial expansion of surviving cells between each round of H5N1 selection (sequential screen; Figure 1A , steps 8b-9). This would allow us to determine if progressive enrichment of sgRNAs occurs at each round of selection, such that genes critical for H5N1 replication are represented by multiple sgRNAs in the earlier rounds. We assessed sgRNA representation at each round of infection in duplicate sample sets up to five rounds. Comparative analysis of sgRNA representation between the A549-GeCKO library and Rd1 of the sequential screen showed no significant differences ( Figures 1B and S1A ). In contrast, we observed robust enrichment of specific sgRNAs at Rd2, with a progressive increase in enrichment occurring between Rd2-5. These data indicate that selection of a cell population less permissive to H5N1 occurs after two rounds of lethal infection.
Next, we performed principle component analysis (PCA) and Pearson correlation analysis to understand the sgRNA distribution pattern between biological replicates in the sequential screen. The sgRNA distribution profile of Replicate one (Rep1, red) and Replicate two (Rep2, blue) at Rd1 clustered together and remained close to the A549-GeCKO library; however, in subsequent rounds (Rd2 to Rd5), the samples belonging to each replicate closely clustered within their respective groups, indicating divergence of replicates after Rd2 ( Figure S1D ). Similarly, comparison of individual sample sets showed strong correlation of sgRNA distribution between Rep1 and Rep2 at Rd1, with a correlation coefficient value of 0.92; however, the correlation coefficient value decreased to %0.25 in subsequent rounds ( Figure S1E ). Although replicate divergence occurred at Rd2, we observed enrichment of specific sgRNAs common in both replicates (Table S1 ). Taken together, these results demonstrate that the robust enrichment seen at Rd2 of the sequential screen occurred concurrently with replicate divergence, yet revealed the progressive enrichment of a common sgRNA population between replicates.
Identification of Genes Enriched during Sequential H5N1 Selection
Next, we performed MAGeCK analysis to identify positively selected genes at Rd2 and Rd5 of the sequential screen (Table S1 ). We observed enrichment of 798 genes (p < 0.05) at Rd2, with 161 genes represented by two or more sgRNAs and 637 genes represented by a single sgRNA ( Figure 1C ). However, we observed enrichment of 501 genes (p < 0.05) at Rd5, with only 16 genes represented by two or more sgRNAs, and 485 genes represented by a single sgRNA. This decrease in the number of genes represented by multiple sgRNAs between Rd2 and Rd5 suggests that stringent H5N1 selection results in the preferential enrichment of individual sgRNAs. To further evaluate the genes identified at Rd5, we compared our hits to factors identified in the nine previously reported genome-wide screens for influenza virus Kö nig et al., 2010;  individual sgRNAs. sgRNAs are distributed by quartile, where the boxes represent the middle quartiles (25%-75% distribution), and the lines and dots represent sgRNAs in the upper and the lower 25% of the distribution. (C) Summary of genes enriched at Rd2 and Rd5 of the sequential screen. sgRNAs enriched during H5N1 selection were identified using the MAGeCK program (p < 0.05) and mapped to corresponding genes. (D) Comparison of hits identified at Rd5 of the sequential screen, excluding miRNAs, with nine genome-wide screens performed for IAV. See also Table S2 . (E) Gene ontology analysis of Rd2 and Rd5 hits from the sequential screen, excluding miRNAs. See also Figure S1 . . Comparative analyses of the hits identified at Rd5 (p < 0.05), excluding miRNAs, indicated that 33 of the 453 hits were also identified in previous screens ( Figure 1D ; Table S2 ). Vacuolar ATPase family members, which were highly represented in six of the prior screens, were also highly enriched in the sequential screen (ATP6AP1, ATP6AP2, ATP6V0A1, ATP6V0B, ATP6V0C, ATP6V1B2, ATP6V1G1, and ATP6V1H) (Mehle and Doudna, 2010; Stertz and Shaw, 2011; Watanabe et al., 2010) . In addition, we identified >400 unique genes, demonstrating that GeCKO screening can reveal previously unidentified IAV host factors.
Next, we used the R package for reactome pathway analysis to identify enriched biological processes and determined that 117 genes from Rd2 and 133 genes from Rd5 (p < 0.05) mapped to known biological processes ( Figure 1E ; Table S3 ) (Yu and He, 2016) . We observed enrichment for genes involved in proton transport and vacuolar acidification, which were represented in the prior genome-wide screens for influenza virus ( Figure 1D ; Table S2 ). We also observed enrichment for genes involved Figure S2 .
in sialic acid biosynthesis, protein glycan modification, and glycosylphosphatidylinositol (GPI)-anchor synthesis, as well as genes involved in intracellular signaling pathways, regulation of cellintrinsic immunity, and autophagy. Therefore, the GeCKO screening confirmed previously described processes, such as vacuolar acidification, and highlighted other processes, including sialic acid biosynthesis and glycan modification, that are important for IAV replication.
Confirmation of Top Hits via
Individual Gene KO To prioritize the candidate host factors for further validation, we identified the common genes in the sequential (Rd5) versus consecutive (Prelim Rd5) screens ( Figure 2A ; Table S4 ). Of the 63 genes in common, we selected 11 highly enriched candidates representing various biological processes for the generation of individual CRISPR KO cell lines (Table 1) . Eight hits (SLC35A1, GDF11, IRX3, C2CD4C, TRIM23, PIGN, ACADSB, and GRAMD2) were also highly enriched (p < 0.05) in the early rounds of selection (Rd2), and the remaining three hits (CIC, JAK2, and PIAS3) demonstrated enrichment only after multiple rounds of selection ( Figure S2 ). To determine if these candidate genes are important for IAV replication, the 11 generated polyclonal KOs were infected with H5N1 at a low multiplicity of infection (MOI). A >60% reduction in viral titer was observed in eight KOs as compared to vector control cells, demonstrating that GeCKO screening was successful in identifying H5N1 host factors in A549 cells ( Figure 2B ).
As we anticipated incomplete disruption of target gene loci in the polyclonal population, we next generated seven clonal KOs for a subset of host factors. Sequence analysis of the sgRNA target sites in the clonal KOs indicated that complete gene disruption was achieved in all but the CIC KOs, which contained a WT allele (Table S5) . We evaluated H5N1 replication in the clonal KOs, and observed an $5 log reduction in viral titer in SLC35A1 and CIC KOs, as well as a >80% reduction in viral titer in the remaining KOs as compared to vector control cells (Figure 2C) . The robust reduction in H5N1 titer observed in the clonal KOs as compared to their respective polyclonal populations suggests that complete gene disruption was required for the validation of candidate host factors. To exclude the possibility of off-target effects in the clonal KOs, we analyzed the sgRNA sequences for potential complementarity in the exons of the human genome (Table S6) . A minimum of 3-4 mismatches were required for identification of potential off-target genes, the majority of which were not enriched at Rd2 and Rd5 of the sequential screen (p < 0.05). As the seven evaluated clonal KOs demonstrated robust reduction in H5N1 viral titer and limited potential for off-target effects, we have thus confirmed that these hits are important for H5N1 replication.
Validation of Hits with Multiple IAV Strains
To determine if the validated host factors are required for the replication of multiple IAV strains, we infected the clonal KOs with H1N1 (A/Puerto Rico/8/1934; PR8) and H3N2 (A/Hong Kong/1/1968; HK68) at a low MOI. We observed a >5 log reduction in viral titer in SLC35A1 KOs and a >3 log reduction in viral titer in CIC KOs as compared to vector control cells ( Figure 2C) . Interestingly, PIAS3 KOs demonstrated strain specificity, as a >80% reduction in viral titer was observed for H1N1 and H5N1, yet H3N2 replication was unaffected. The remaining clonal KOs showed a >60% reduction in viral titers for both H1N1 and H3N2, demonstrating that the identified host factors are important for efficient replication of multiple IAV strains.
To distinguish between IAV-specific host factors and those that function in a pan-proviral manner, we assayed the replication of vesicular stomatitis virus (VSV) in the clonal KOs. VSV replication was unaffected in SLC35A1 and PIGN KOs; however, we observed a >2 log reduction in viral titer in CIC KOs and a R50% reduction in viral titer in the remaining KOs ( Figure 2C ).
Taken together, these data suggest that SLC35A1 and PIGN are IAV-specific host factors, whereas C2CD4C, TRIM23, CIC, JAK2, and PIAS3 may function in a pan-proviral manner to support viral replication.
Identification of Viral Life-Cycle Defects in Clonal KO Cells To elucidate the mechanism by which the identified host factors contribute to IAV replication, we evaluated various stages of the viral life cycle in a subset of clonal KOs. First, to identify host factors that are critical for a single IAV infection cycle, we performed synchronized infections at a high MOI with H5N1. We observed an $1-2 log reduction in viral titer in SLC35A1 and in CIC KOs as compared to vector control cells, indicating that loss of these host factors resulted in inefficient establishment or completion of the viral life cycle ( Figure 3A ). In contrast, the remaining clonal KOs displayed only modest differences in viral titer, suggesting that the defects observed at a low MOI were due to the cumulative effects of multiple replication cycles.
Next, we utilized beta-lactamase carrying influenza virus-like particles (flu VLPs) to measure the ability of the clonal KOs to support virion entry and/or fusion, in comparison to VSV glycoprotein (VSV-G) VLPs . SLC35A1 KOs showed robust restriction of IAV entry and/or fusion, as only $3.6% of cells were positive for flu VLP infection ( Figure 3B ). In addition, only 25% of PIAS3 KOs were positive for flu VLP infection, suggesting a role for PIAS3 in IAV entry and/or fusion. In contrast, no defects in flu VLP infection were observed for the remaining KOs, and VSV-G VLP infection was largely unaffected in all of the tested KOs. These results demonstrate that SLC35A1 and PIAS3 play a critical role in the entry and/or fusion stage of the IAV life cycle.
To determine if the remaining host factors are required at a post-fusion stage of the IAV life cycle, we measured primary viral transcription and viral genome replication of H1N1 in the clonal KOs. At 3 hpi, primary nucleoprotein (NP) transcript (NP mRNA) and input viral genomic NP RNA (NP vRNA) levels were measured by qRT-PCR. As SLC35A1 KOs demonstrated defects in viral entry and/or fusion, we observed low levels of input NP vRNA and consequently low levels of NP transcription as compared to vector control cells ( Figure 3C ). Interestingly, NP mRNA levels were reduced >90% in CIC KOs as compared to vector control cells, despite displaying similar levels of input NP vRNA. Next, we assessed the clonal KOs for defects in viral genome replication at 6 hpi by qRT-PCR. In CIC KOs, we observed an $80% reduction in both NP vRNA and mRNA as compared to vector control cells, indicating that the observed reduction in primary transcription impaired subsequent genome replication. Thus, CIC KOs demonstrate a defect in IAV replication at a stage between post-fusion and primary transcription.
As dysregulation of cell-intrinsic immunity may inhibit IAV replication, we evaluated the expression of antiviral genes by qRT-PCR under basal (mock) and H1N1-infected conditions. CIC and JAK2 KOs demonstrated an increase in antiviral gene expression (>2-fold) for both mock and H1N1-infected conditions as compared to vector control cells ( Figures 3D, 3E , and S3A). Interestingly, in comparison to vector control cells, PIAS3 KOs displayed higher antiviral gene expression only upon IAV infection. To further validate our findings, we confirmed the loss of JAK2 protein expression in JAK2 KOs by western blot analysis ( Figure S3B ). In addition, we complemented JAK2 KOs with cDNA expressing JAK2 and observed increased viral replication (R1 log) as compared to GFP expressing JAK2 KOs, indicating that only loss of the JAK2 gene resulted in the observed viral replication defects in JAK2 KOs ( Figure S3C ). These data demonstrate that CIC, JAK2, and PIAS3 KOs display dysregulated antiviral gene expression. Taken together, our studies show that SCL35A1 KOs display defects in viral entry and/or fusion and CIC KOs demonstrate restriction of IAV replication between post-fusion and primary transcription as well as dysregulation of antiviral gene expression. ( Figure 4A ). In our GeCKO screen, we observed enrichment of host factors involved in sialic acid biosynthesis (GNE, CMAS), transport (SLC35A1, SCL35A2), glycan modification/processing (DPM2, ALG3, ALG4, ALG12, GANAB, A4GALT, B3GAT1, B4GALNT4, CHSY1, CSGALNACT2, and HS3ST6) and GPI-anchor synthesis (PIGN, DPM2) ( Figures 4A and S4A ). Of these host factors, SLC35A1 was the highest enriched gene and was represented by 3 independent sgRNAs ( Figure S2 ). As SLC35A1 is a CMP-sialic acid (CMP-Neu5Ac) transporter, we hypothesized that SLC35A1 KOs lack cell-surface sialic acids (Hadley et al., 2014) . To this end, we used specific lectins to detect 2 0 -3 0 (Maackia amurensis lectin [MAL]) or 2 0 -6' (Sambucus nigra lectin [SNA]) linked sialic acid on the cell surface. Flow cytometry and confocal microscopy analyses of SLC35A1 KOs showed a lack of binding for both types of lectins as compared to vector control cells, indicating the loss of cell-surface sialic acid in the absence of SLC35A1 (Figures 4B and 4C) . Next, we evaluated the efficiency of recombinant HA (H5) binding. SLC35A1 KOs were unable to support HA binding as compared to vector control cells, indicating that the reduced susceptibility of SLC35A1 KOs was due to inefficient binding of IAV particles to the cell surface ( Figure 4D) . (legend continued on next page)
SLC35A1 Is Required for IAV Entry
As there are currently no inhibitors available against SLC35A1, we sought to determine if inhibition of downstream sialyltransferases with 3Fax-Peracetyl Neu5Ac (3F-Neu5Ac), a CMPNeu5Ac analog, would inhibit IAV replication (Rillahan et al., 2012) . Treatment of WT A549 cells with 3F-Neu5Ac resulted in robust restriction of H1N1 and H3N2 replication as compared to DMSO-treated cells ( Figure 4E ). Interestingly, H5N1 replication was unaltered in 3F-Neu5Ac-treated cells, despite displaying almost complete loss of lectin binding ( Figure 4F ). To exclude the possibility of other defects that may result in the restriction of IAV infection in SLC35A1 KOs, we complemented SLC35A1 KOs with cDNA expressing SLC35A1. We observed increased IAV replication in complemented SLC35A1 KOs, yet observed no differences in VSV replication ( Figure 4G ). In addition, expression of SLC35A1 in WT A549 cells did not alter IAV replication (Figure S4B ). These studies demonstrate that SLC35A1 facilitates incorporation of sialic acid moieties onto cell-surface proteins, and thus is an essential host factor for IAV entry.
Capicua Is a Negative Regulator of Cell-Intrinsic Immunity Our studies show that capicua (CIC) is critical for both IAV and VSV replication ( Figure 2C ). CIC is a conserved DNA-binding transcriptional repressor that functions in conjunction with the co-repressor Ataxin1 (ATXN1) or its paralog ATXN1-Like (ATXN1L) (Ajuria et al., 2011; Jimé nez et al., 2012 ). There are two major isoforms of CIC: short (CIC-S) and long (CIC-L), expressed from independent start codons ( Figure S5A ). To further understand the role of CIC in virus replication, we first confirmed our findings in new CIC KOs generated with an independent sgRNA (CIC KO2s). Loss of CIC expression in CIC KO2s was confirmed by western blot analysis and sequencing of the sgRNA target site ( Figure S5B ; Table S5 ). In agreement with previous findings, we observed decreased levels of ATXN1L protein as well as increased expression of a CIC-regulated gene, ETV4, in CIC KO2s ( Figures S5B and S5C) (Dissanayake et al., 2011; Lee et al., 2011) . As previously observed, CIC KO2s also demonstrated an $2-3 log reduction in the replication of various IAV strains, as well as a R 1 log reduction in VSV, encephalomyocarditis virus (EMCV), and Zika virus replication ( Figures 2C and 5A ). As anticipated, we observed higher antiviral gene expression in CIC KO2s under basal (mock) and H1N1-infected conditions as compared to vector control cells (Figures 5B-5D ). Together, these data suggest that loss of CIC results in a heightened antiviral state, rendering cells less permissive to viral replication.
As loss of CIC resulted in higher antiviral gene expression, we hypothesized that ectopic expression of CIC would suppress the activity of antiviral gene promoters. Thus, we generated luciferase reporters under the control of the human IFIT1 and MxA promoters. Co-expression of CIC and ATXN1 resulted in a dose dependent decrease in IFIT1 reporter activity (up to $50%) upon RIG-I stimulation as compared to GFP control, to a greater extent than expression of CIC or ATXN1 alone (Figure 5E) . Similarly, an $40% reduction in MxA reporter activity was observed upon co-expression of CIC and ATXN1. As our results indicate that CIC can repress antiviral gene expression, we investigated if downregulation of CIC occurs upon infection to facilitate the induction of antiviral genes.
Western blot analysis of H1N1-infected vector control cells demonstrated a rapid decline in CIC protein levels between 40-60 min post-infection ( Figure 5F ). qRT-PCR analysis of H1N1-infected vector control cells showed an $50% decrease in CIC mRNA levels, demonstrating that both CIC mRNA and protein levels are downregulated in response to IAV infection ( Figure 5G ). Taken together, GeCKO screening has identified CIC as a negative regulator of cell-intrinsic immunity.
DISCUSSION
Here, we performed a GECKO screen using a human isolate of an avian H5N1 strain and identified host factors critical for IAV entry and regulation of cell-intrinsic immunity. Cells lacking the sialic acid transporter SLC35A1 were highly enriched post-H5N1 selection, as they were deficient in the viral receptor and thus were incapable of supporting HA binding. sgRNAs targeting several genes involved in sialic acid biosynthesis and related glycosylation pathways were also enriched during H5N1 selection. In addition, we identified CIC, a DNA-binding transcriptional repressor, as a key regulator of cell-intrinsic immunity. CIC-deficient cells demonstrated upregulated antiviral gene expression and decreased replication of multiple viruses. Taken together, GeCKO screening can be a powerful tool to discover host factors and to highlight biological pathways essential for the replication of intracellular pathogens.
For this study, we employed a pooled GeCKO approach, relying upon gene disruption and stringent selection to enrich for a cell population resistant to IAV infection. As opposed to siRNA-based screening, it has been reported that cell-survival-based GeCKO screens for viral host factors predominantly reveal hits that support early steps of viral replication Savidis et al., 2016) . Similarly, we observed robust enrichment of host factors important for sialic acid (IAV receptor) expression as well as vacuolar acidification and endocytosis ( Figure 1E ; Table S3 ). Of these identified entry factors, several members of the vacuolar ATPase family were previously identified in multiple siRNA screens (Mehle and Doudna, 2010; Stertz and Shaw, 2011b; Watanabe et al., 2010 ; Figure 1D ; Table S2 ). Interestingly, SLC35A1 was (legend continued on next page) identified in only one of the prior siRNA screens, and knockdown demonstrated an $50% decrease in H1N1 (PR8) infection . In this GeCKO screen, SLC35A1 was the highest enriched hit and gene knockout displayed an $5 log decrease in viral replication for multiple IAV strains (Figure 2C ). In addition, several host factors critical for sialic acid biosynthesis and related glycosylation pathways were uniquely enriched in this GeCKO screen ( Figures 4A and S4A ) (Chu and Whittaker, 2004; de Vries et al., 2012) . In agreement, a survivalbased haploid screen for enterovirus D68, which also utilizes sialic acid as an entry receptor, showed enrichment of host factors necessary for cell-surface sialic acid expression (Baggen et al., 2016) . Thus, survival-based GeCKO screening allows for the identification of host factors critical for the early steps of viral replication. In addition to the identification of viral entry host factors, GeCKO screening revealed factors important for the regulation of cell-intrinsic immunity. In our validation studies, we observed higher levels of antiviral gene expression in CIC, JAK2, and PIAS3 KOs ( Figures 3D and 3E) ; however, loss of these host factors impacted different steps of the IAV life cycle ( Figures  3A-3C) . JAK2 was previously identified in one of the siRNA screens and implicated in IAV entry (Kö nig et al., 2010) . However, in JAK2 KOs, we observed no defects in flu VLP entry yet decreased genome replication at 6 hpi. It is possible that increased antiviral gene expression may suppress IAV genome replication in JAK2 KOs. In another study, JAK2 was implicated in the intracellular localization of the viral M1 protein through tyrosine phosphorylation (Kö nig et al., 2010; Wang et al., 2013) . Therefore, further studies are necessary to delineate the role of JAK2 in IAV replication. In PIAS3 KOs, we observed increased antiviral gene expression only upon IAV infection, as well as defects in flu VLP entry and primary transcription. Interestingly, PIAS3, an E3 SUMO ligase, has been shown to SUMOylate RAC1 and modulate cytoskeletal rearrangement; thus, it is possible that PIAS3 plays a role in IAV endocytosis (Castillo-Lluva et al., 2010) . In addition, it has previously been shown that PIAS1 and PIAS3 negatively regulate STAT-mediated signaling and IRF1 transcriptional activity, suggesting that PIAS3 may be important for modulating cell-intrinsic immunity (Nakagawa and Yokosawa, 2002) . These findings suggest that JAK2 and PIAS3 are important for the regulation of cellintrinsic immunity, yet may function at different steps of the IAV life cycle.
CIC in conjunction with the co-repressor Ataxin1 (ATXN1) or its paralog ATXN1-like (ATXN1L) has been implicated in cancer development and progression, as well as neuropathology and autoimmunity (Bettegowda et al., 2011; Lam et al., 2006; Okimoto et al., 2017; Park et al., 2017b) . However, CIC has not been shown to play a role in the regulation of cell-intrinsic immunity. In our validation studies, we observed robust restriction of RNA viruses from diverse families and increased antiviral gene expression in CIC KO2s (Figures 5A-5D ). In agreement, a previous study demonstrated increased levels of proinflammatory cytokines in CIC-L-deficient mice . In addition, we observed repression of IFIT1 and MxA reporter activity upon ectopic expression of CIC with the corepressor ATXN1 ( Figure 5E ). As CIC has been previously demonstrated to function as a DNA-binding transcriptional repressor, it is possible that CIC suppresses antiviral gene expression via its transcriptional repressor activity (Jimé nez et al., 2012) . Furthermore, our studies demonstrate downregulation of CIC protein and RNA levels upon IAV infection (Figures 5F and 5G) . As viral infections activate MAPK pathways, and the activation of MAPK pathways result in the downregulation of CIC, it is possible that CIC degradation during IAV infection occurs via MAPK signaling (Ajuria et al., 2011; Dissanayake et al., 2011; Pleschka, 2008) . Previous studies show that CIC degradation can be inhibited by the COP9 signalosome (Suisse et al., 2017) . Interestingly, multiple members of the COP9 complex have been identified as IAV host factors; thus, it is tempting to speculate that viruses may usurp the COP9 signalosome to prevent CIC degradation and thereby repress host antiviral gene expression (Tripathi et al., 2015) . Future studies will determine the mechanisms of CIC regulation during viral infection.
In conclusion, GeCKO screening is a powerful alternative strategy for the identification of host factors and biological pathways critical for the replication of multiple influenza viruses. Host pathways required for expression of the viral receptor sialic acid were uniquely enriched in this GeCKO screen, with the highest enrichment observed for SLC35A1, a sialic acid transporter. In addition to highlighting biological pathways, our GeCKO screen identified CIC as a host factor important for the regulation of cell-intrinsic immunity. Our studies show that CIC suppresses antiviral gene expression and suggest that CIC levels are regulated during viral infection to facilitate robust induction of antiviral responses. Therefore, we demonstrate that GeCKO screening is an invaluable tool for the discovery of host factors essential for the replication of intracellular pathogens and for the identification of targets for the development of host-directed therapeutics.
(D) Western blot analysis of antiviral gene expression in basal (mock) or in H1N1-infected conditions. Vector control and CIC KO2s were infected with H1N1 (MOI = 5), and cell lysates were analyzed at 16 hpi. (E) IFIT1 and MxA reporter activity upon ectopic expression of CIC and ATXN1. Firefly luciferase reporters under the control of IFIT1 or MxA promoters were transfected in the presence or in the absence of RIG-I-2CARD, CIC, and ATXN1, and luciferase activity was measured at 48 hr post-transfection. Data are represented as percent luciferase activity relative to GFP + RIG-I-2CARD-transfected control ± SD. (F) Western blot analysis of CIC degradation upon H1N1 infection. Vector control and CIC KO2s were infected with H1N1 (MOI = 3), and cell lysates were analyzed at the indicated times. (G) qRT-PCR analysis of CIC downregulation upon H1N1 infection. WT A549s were infected with H1N1 (MOI = 5), and CIC mRNA levels were measured at 16 hpi. Data are represented as the fold expression relative to uninfected (mock) WT A549s ± SD. For (D) and (F), Ku levels are shown as loading controls. * p < 0.05; ns, non-significant. Data are representative of at least three independent experiments. See also Figure S5 .
EXPERIMENTAL PROCEDURES A549-GeCKO Library Generation and H5N1 Screen
The A549-GeCKO library was generated using the lentiGuide-Puro (#52963, Addgene) two-vector system for Cas9 and sgRNA delivery as previously described . Briefly, Cas9-A549 cells were generated via lentivirus transduction of the Cas9 transgene (lentiCas9-BLAST, #52962, Addgene), followed by selection with 5 mg/ml blasticidin. Clonal Cas9-A549 cells were further transduced with lentivirus particles containing the human sgRNA library (Human GeCKO v2 Library A Cat#1000000049, Addgene) at MOI = 0.3 to attain no greater than 1 sgRNA per cell and selected with both 1 mg/ml puromycin and 5 mg/ml blasticidin for 14 days to achieve >95% gene disruption . For the preliminary consecutive screen, 2 3 10 8 A549-GeCKO library cells were infected with VN04 Low (H5N1) at MOI = 5 in infection media for 2 days. Surviving cells were reseeded in DMEM supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S) solution and subjected to four more rounds of infection. The surviving resistant population was expanded to 1 3 10 7 cells and subjected to deep sequencing analysis. For the sequential screen, 2 3 10 8 A549-GeCKO library cells were infected with VN04 Low (H5N1) at MOI = 5 in infection media for 2 days in biological duplicates, and the surviving cells were allowed to expand ($2-4 3 10 7 ). Onefifth of the expanded cells were utilized for deep sequencing analysis, and four-fifths of the expanded cells were subjected to the next round of infection.
Statistical Analysis
Statistical significance was determined by two-tailed unpaired Student's t test, and p values %0.05 are considered significant and denoted with an asterisk. Non-significant values are denoted as ns. Additional experimental procedures are included in the Supplemental Experimental Procedures.
DATA AND SOFTWARE AVAILABILITY
The accession number for the deep sequencing data reported in this study is GEO: GSE111166.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, five figures, and seven tables and can be found with this article online at https://doi.org/10.1016/j.celrep.2018.03.045.
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Deep Sequencing and Bioinformatics Analysis
Genomic DNA (gDNA) was isolated from 1x10 8 cells for the A549-GeCKO library and 4-10x10 6 cells for the Preliminary Consecutive Screen and the Sequential Screen, using the Blood and Cell Culture Maxi Kit or Mini Kit (Qiagen) per the manufacturer's specifications. The integrated sgRNA cassette was PCR amplified using EconoTaq DNA Polymerase (Lucigen) in two steps as previously described .
Briefly, the initial PCR for the A549-GeCKO library gDNA consisted of 13 separate reactions using 10µg gDNA each, and the resulting amplicons were combined.
Amplification of the sgRNA cassette from the Preliminary Consecutive Screen and the Sequential Screen gDNA was performed as described with 9 separate reactions for the initial PCR. Nested PCR was then performed using 5µl of combined PCR product each in 9 separate reactions to incorporate Illumina linkers and a 1-9nt variable region. The resulting amplicons were gel extracted and combined in equivalent amounts prior to deep sequencing. PCR fragments were assessed using an Agilent 2100 Bioanalyzer and a 4nM library was applied to a standard MiSeq Flow Cell (MiSeq Reagent Kit v3) and run for 150 cycles. The occurrence of sgRNA indexes were summarized with the Bioconductor Biostrings package (PDict class) (Pags, 2016) . Enriched genes were identified via MAGeCK, a Model-based Analysis of Genome-wide CRISPR/Cas9
Knockout method for prioritizing single-guide RNAs, genes, and pathways in genomescale CRISPR/Cas9 knockout screens . For the Preliminary Consecutive Screen, the A549-GeCKO library sample set was used to calculate sgRNA enrichment for Prelim Rd5 and the corresponding genes were identified as candidate hits (p-value <0.1). For the Sequential Screen, the average of the Rd1 sample set was used to calculate sgRNA enrichment for Rd2 and Rd5, and corresponding genes were identified as candidate hits (p-value <0.05). Pairwise comparison was performed with the top hits from Rd5 of the Sequential Screen, excluding miRNAs, and the validated hits from the 9 published IAV siRNA screens , Konig et al., 2010 . Gene ontology analysis of hits identified in Rd2 and Rd5 of the Sequential Screen, excluding miRNAs, was performed with an R package for
Reactome Pathway Analysis to identify enriched biological processes, and the gene annotations are listed in Table S3 (Yu and He, 2016) . For analysis, R was used to assist in the exploration and summarization of the results (RCoreTeam, 2014) .
Generation of CRISPR KO and Complemented Cells
CRISPR KO A549 cell lines were generated using the lentiCRISPR v2 (#52961, Addgene) single vector system as previously described . Briefly, annealed oligonucleotides were cloned into the lentiCRISPR v2 vector via BsmBI sites.
Oligonucleotide sequences for the gene specific sgRNAs are listed in Table S7 .
Polyclonal CRISPR KO A549 cells were generated via lentivirus transduction of the gene specific sgRNA containing vector followed by selection with 1µg/ml puromycin for 14 days. Vector control cells were generated as above, using the lentiCRISPR v2
vector. For generation of clonal KO A549 cells, lentiCRISPR v2 transduced cells were seeded in limiting dilutions and individual clones were isolated. gDNA was extracted from monoclonal KO cells using the Blood and Cell Culture Mini kit (Qiagen) per the manufacturer's specifications, and the targeted region was PCR amplified using EconoTaq and the gene specific primers listed in Table S7 . Likewise, total RNA was extracted from clonal KO cells using TRIzol (Invitrogen) per the manufacturer's guidelines, cDNA was generated using Superscript II reverse transcriptase (Invitrogen) and Oligo dT (Invitrogen) per the manufacturer's instructions, and the targeted region was PCR amplified using Econotaq and the gene specific primers listed in Table S7 .
PCR products were cloned into pGEM-T (Promega) per the manufacturer's recommendations, and ≥ 8 clones per gene were sequenced by Sanger Sequencing.
In/Dels were analyzed for each gene using SeqMan (Lasergene, DNAStar Inc) and are summarized in Table S5 .
SLC35A1 cDNA in a lentivirus plasmid (pLX304 vector) was purchased from DNASU Plasmid Repository at Arizona State University (https://dnasu.org/). SLC35A1 KO cells or WT A549 cells were transduced with lentivirus particles carrying GFP or SLC35A1 cDNA and selected with 5µg/ml blasticidin for 5 days. JAK2 cDNA was purchased from
Harvard Plasmid Repository and subcloned into the pLX304 vector. JAK2 cDNA complementation in JAK2 KO cells was performed as described above.
Virus Infections
For WT A549 cells, we observe a peak viral titer of 10 6 -10 7 PFU/ml (IAV), 10 8 -10 9 PFU/ml (VSV), and 10 5 -10 6 PFU/ml (Zika virus) at 48hpi, and 10 7 -10 8 PFU/ml (EMCV) at 24hpi.
For analysis of ISG expression, vector control and clonal KO cells were seeded in triplicate at a density of 1.2x10 6 cells per well in a 6-well dish, and cell numbers were measured the next day prior to treatment/infection. Cells were mock treated or inoculated with H1N1 (PR8) at MOI=5 in DMEM supplemented with 0.2% BSA and 1% P/S at 37ºC for 16hrs prior to RNA or protein isolation. CIC downregulation experiments were performed in WT A549 cells as described above.
For synchronized infections, cells were seeded as described above. Cells were washed twice with PBS, placed in ~750µl infection media, prechilled on ice for 15min, mock treated or inoculated with H1N1 at MOI=3 for 1hr on ice, washed twice in PBS, and placed in 2ml of fresh infection media for the indicated times at 37ºC prior to RNA isolation or RIPA lysis.
QPCR Analysis of Host Gene Expression
Total RNA was isolated from pooled triplicates using TRIzol (Invitrogen) and residual gDNA was removed with recombinant DNAse I (Roche) per the manufacturer's recommendations. For analysis of ISG expression, cDNA was generated using 
Primary Transcription and Early Replication Assays
For measurement of viral NP expression during primary transcription, vector control or clonal KO cells were pretreated with ~750µl infection media containing 100µg/ml cycloheximide (MP Biomedicals) for 1hr at 37ºC, synchronized infections were performed as described above, and RNA was isolated at 3hpi. For measurement of viral NP expression during early replication, synchronized infections were performed as described above (without cycloheximide treatment) and RNA was isolated at 6hpi. Total 
Western Blot Analysis
Whole cell extracts from pooled triplicates were lysed using RIPA buffer containing protease inhibitors and western blot analysis was performed with ~80ug of total protein.
Confirmation of gene KO was performed in untreated vector control and clonal KO cells.
CIC degradation analysis was carried out in vector control and CIC KO2 cells and synchronized infections were performed as described above. Antibodies used for western blot analysis are as follows -JAK2 (#3230T) and MxA (#37849) from Cell Signaling Technologies; b-actin (#A5316) and Ku (#K2882) from Sigma; RIG-I (1C3 clone) (Nistal-Villan et al., 2010) ; ISG56 or IFIT1 (#PA3-848) from Thermo Scientific, CIC and ATXN1L .
VLP Entry Assay
The beta-lactamase-M1 (Bla-M1) based VLP assay was performed as previously described . Briefly, VLPs were produced by co-transfecting 
Lectin and HA Binding Assays
Biotinylated Sambucus Nigra (SNA) and Maackia Amurensis Lectin II (MAL) lectins were purchased from Vector Biolabs. Vector control and SLC35A1 KO cells were fixed with 4% formaldehyde for 10min, washed with PBS twice and incubated with 20µg/ml biotinylated lectin for 1hr on ice, followed by staining with 1µg/ml Streptavidin conjugated to Brilliant Violet 605 (BioLegend). The levels of lectin binding were visualized using a confocal microscope, or analyzed by a BD LSRII flow cytometer. Cell surface binding of HA was performed with purified H5 HA protein (BEI Resources).
Briefly, cells were incubated with 5µg of HA on ice for 1hr and the unbound protein was removed by PBS/BSA washes. Cells were fixed with 4% formaldehyde for 10min and washed with PBS/BSA. The amount of bound HA was measured using cell surface staining for HA with an anti-H5 mouse sera followed by a secondary antibody conjugated to Alexa-647, and analyzed by flow cytometry on a BD LSRII instrument.
Data analysis was performed using FlowJo Software.
Treatment with 3F-Neu5Ac
3Fax-Peracetyl Neu5Ac (3F-Neu5Ac) was purchased from Millipore. WT A549 cells were treated with DMSO or 200µM 3F-Neu5Ac for a period of 10 days to eliminate residual sialic acid from the cell surface. Lectin binding analysis was performed as described above. Viral infections were performed at an MOI=0.1 and viral titers in the supernatants at 18hpi were assessed by plaque assay as described above.
Antiviral Promoter Reporter Assay
Fragments containing ~3kb of the promoters for the antiviral genes IFIT1 and MxA were PCR amplified and cloned into the pXPG vector (Addgene #71248) using hIFIT1: 
Statistical Analysis
Statistical significance was determined by two-tailed unpaired Student's t test, and pvalues ≤ 0.05 are considered significant and denoted with an asterisk. Non-significant values are denoted as ns.
